Teva Pharmaceutical Industries (TEVA) Net Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | 948.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -990.00 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -1,504.00 |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | 675.00 |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn | 787.00 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -228,760.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 427.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | -163.00 |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn | 17,272.00 |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 948.00 |
| Mar 31, 2026 | 1,620.00 |
| Dec 31, 2025 | 4,432.00 |
| Sep 30, 2025 | 786.00 |
| Jun 30, 2025 | 1,407.00 |
| Mar 31, 2025 | 3,223.00 |
| Dec 31, 2024 | -580.00 |
| Sep 30, 2024 | -1,694.00 |
| Jun 30, 2024 | -2,641.00 |
| Mar 31, 2024 | 1,153.00 |
| Dec 31, 2023 | 709.00 |
| Sep 30, 2023 | 11,130.00 |
| Jun 30, 2023 | -2,701.00 |
| Mar 31, 2023 | -849.00 |
| Dec 31, 2022 | -3,681.00 |
| Sep 30, 2022 | 945.00 |
| Jun 30, 2022 | 915.00 |
| Mar 31, 2022 | -2,405.00 |
| Dec 31, 2021 | 6,285.00 |
| Sep 30, 2021 | 1,410.00 |